Tremor-reducing GyroGlove set to launch in 2017

Advances

Author: Parkinson's Life editorsPublished: 29 December 2016

Prep: Cook: Serves:

Inventors of GyroGlove announce plans to put the innovative ‘wearable’ into production in the coming year

The company behind GyroGlove has announced plans to bring the tremor-reducing device into production in 2017, following final testing and prototype development.

Founder Faii Ong, said: “We are in the midst of our last round of comprehensive modelling followed by prototyping for manufacture. After months of much grimacing, testing, caffeine and gnashing of teeth, the modelling results confirm all the live testing and data.”

GyroGlove is hi-tech glove that mechanically stabilises hands for people living with Parkinson’s. Further testing will begin in March 2017 and the company is calling for more volunteers to take part in the process.

Image credit: GyroGear

Sign up here to join the GyroCircle test volunteers group

Last Month

Next Month

Go Back

Share this story

Comments

Health & Fitness

6 tips to stay active while living with Parkinson’s disease

Tips to keep fit and stay active with Parkinson’s

Comedy stars unite for ‘Shake with Laughter’

‘Shake with Laughter’ returns to London

Rock and stroll in NYC – US Unity Walk

Thousands to join Michael J Fox and May May Ali at US Unity Walk

World War II weapon antidote could treat Parkinson’s

Researchers at Purdue University, US, are studying a World War II chemical weapon antidote that they believe could be used to treat Parkinson’s. It is believed the antidote, called dimercaprol, may be able to remove acrolein – a toxin that poisons neurons and can lead to the development of Parkinson’s disease. In addition to this, researchers believe dimercaprol can increase the survival rate of brain cells, improve mobility and reduce symptoms of pain. Riyi Shi, professor of neuroscience and biomedical engineering at Purdue University, said: “Our studies show that by removing the toxin (acrolein) from the brain, we are not just reducing the symptoms of Parkinson’s disease but also significantly reversing the damage of Parkinson’s disease. This could actually provide a new treatment for Parkinson’s patients.”

Repurposed cancer drug shows promise for Parkinson’s

Researchers at the Oxford Parkinson’s Disease Centre, UK, have repurposed an experimental cancer drug – called tasquinimod – as a potential treatment for Parkinson’s. The study – funded by Parkinson’s UK and published in science journal ‘Cell Stem Cell’ – has been tested on a total of 10 patients so far. As part of the research, the study grew brain cells from donated skin cell samples of people living with a rare genetic form of Parkinson’s – this process was then repeated on people with a common non-genetic form of the condition. Researchers found that tasquinimod can block HDAC4, a protein that causes Parkinson’s genes to become inactive. Professor Richard Wade-Martins, co-lead author of the study, said: “We think that switching off these genes in brain cells may play a vital role in the cell damage and death that occurs in Parkinson’s.”

Research survey assesses impact of holidays on Parkinson’s symptoms

The Radboud University Medical Center, Netherlands, is seeking participants for an online survey assessing the effects of a holiday on Parkinson’s. The study will assess whether a vacation can have physical and mental benefits for people living with the condition. It will also look at which specific factors, such as temperature and physical activity, can alleviate or increase symptoms. The Michael J Fox Foundation has approved the study’s protocol. Participants can sign up to complete the 20-minute survey online. The survey is open to anyone over 18 who has Parkinson’s and has been on vacation once or more between 1 June 2016 and 30 September 2018. Marjan Faber, the study’s daily supervisor, said: “If the study is able to identify decisive factors, those can act as a starting point for novel approaches in care for people with Parkinson’s disease.” To apply please visit research platform ParkinsonNEXT.

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
Captcha
*
- By proceeding you agree to our
Email
This field is for validation purposes and should be left unchanged.

Tremor-reducing GyroGlove set to launch in 2017

Advances

Author: Parkinson's Life editorsPublished: 29 December 2016

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Health & Fitness

6 tips to stay active while living with Parkinson’s disease

Perspectives

Comedy stars unite for ‘Shake with Laughter’

Global update

Rock and stroll in NYC – US Unity Walk

World War II weapon antidote could treat Parkinson’s

Repurposed cancer drug shows promise for Parkinson’s

Research survey assesses impact of holidays on Parkinson’s symptoms

{title}

Subscribe

Tremor-reducing GyroGlove set to launch in 2017

Advances

Author: Parkinson's Life editorsPublished: 29 December 2016

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Health & Fitness

6 tips to stay active while living with Parkinson’s disease

Perspectives

Comedy stars unite for ‘Shake with Laughter’

Global update

Rock and stroll in NYC – US Unity Walk

World War II weapon antidote could treat Parkinson’s

Repurposed cancer drug shows promise for Parkinson’s

Research survey assesses impact of holidays on Parkinson’s symptoms

{title}

Subscribe

Sign in